is a CRAMS/CDMO player offering discovery and development services for pharma. It benefits from global outsourcing of drug discovery and early‑stage development. R&D capabilities and compliant facilities underpin its positioning. Risks include client and project concentration, regulatory inspections, and capex funding.

#WatchOutFor#EquityResearch#Miscellaneous#FundamentalViews#TechnicalViews

949 likes·25 comments